Shionogi Files Oral COVID Antiviral In Japan, Vaccine Shows Phase III Promise

Once-Daily Dosing Option

 
• By Lisa Takagi
  
Tokyo skyline and Mountain Fuji in Japan
Progress in Japan For Shionogi's oral antiviral and vaccine for COVID-19 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia